Atea Pharmaceuticals shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Atea Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Atea Pharmaceuticals held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Atea Pharmaceuticals by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $968k | 240k | 4.04 |
| 2023-12-31 | $779k | 255k | 3.05 |
| 2023-09-30 | $964k | 321k | 3.00 |
| 2023-06-30 | $1.2M | 321k | 3.74 |
| 2023-03-31 | $1.0M | 310k | 3.35 |
| 2022-12-31 | $1.5M | 321k | 4.81 |
| 2022-09-30 | $1.7M | 307k | 5.69 |
| 2022-06-30 | $1.9M | 270k | 7.10 |
| 2022-03-31 | $2.0M | 277k | 7.22 |
| 2021-12-31 | $2.5M | 278k | 8.93 |
| 2021-09-30 | $9.1M | 259k | 35.06 |
| 2021-06-30 | $4.2M | 196k | 21.48 |
| 2021-03-31 | $2.7M | 44k | 61.79 |
| 2020-12-31 | $1.5M | 37k | 41.78 |